Structures by: Al-Tamimi A. S.
Total: 10
3-(1-Adamantyl)-1-{[4-(2-methoxyphenyl)piperazin-1-yl]methyl}-4-methyl- 1<i>H</i>-1,2,4-triazole-5(4<i>H</i>)-thione
C25H35N5OS
Acta Crystallographica Section E (2010) 66, 7 o1756
a=11.0203(2)Å b=12.1148(2)Å c=18.7624(4)Å
α=90.00° β=103.4730(10)° γ=90.00°
<i>N</i>'-[(2-<i>n</i>-Butyl-4-chloro-1<i>H</i>-imidazol-5- yl)methylidene]adamantane-1-carbohydrazide sesquihydrate ethanol hemisolvate
C19H27ClN4O,0.5C2H6O,1.5H2O
Acta Crystallographica Section E (2010) 66, 8 o2131
a=7.9867(6)Å b=16.8478(13)Å c=16.9656(13)Å
α=97.3410(10)° β=100.3760(10)° γ=97.5050(10)°
3-(Adamantan-1-yl)-1-[(4-benzylpiperazin-1-yl)methyl]-4-[(<i>E</i>)-(2- hydroxybenzylidene)amino]-1<i>H</i>-1,2,4-triazole-5(4<i>H</i>)-thione
C31H38N6OS
Acta Crystallographica Section E (2012) 68, 6 o1766-o1767
a=10.6015(5)Å b=12.0283(7)Å c=22.7865(12)Å
α=90.00° β=101.222(4)° γ=90.00°
3-(Adamantan-1-yl)-1-[(4-ethylpiperazin-1-yl)methyl]-4-[(<i>E</i>)-(4- hydroxybenzylidene)amino]-1<i>H</i>-1,2,4-triazole-5(4<i>H</i>)-thione
C26H36N6OS
Acta Crystallographica Section E (2012) 68, 3 o657-o658
a=16.1006(6)Å b=14.2182(5)Å c=11.4641(4)Å
α=90.00° β=92.440(4)° γ=90.00°
3-(Adamantan-1-yl)-4-methyl-1-[(4-phenylpiperazin-1-yl)methyl]-1<i>H</i>- 1,2,4-triazole-5(4<i>H</i>)-thione dichloromethane hemisolvate
2(C24H33N5S),CH2Cl2
Acta Crystallographica Section E (2012) 68, 6 o1772-o1773
a=66.8490(16)Å b=22.1076(4)Å c=6.51090(10)Å
α=90.00° β=90.00° γ=90.00°
3-(Adamantan-1-yl)-4-[(<i>E</i>)-(2,6-difluorobenzylidene)amino]-1-[(4-ethylpiperazin-1-yl)methyl]-4,5-dihydro-1<i>H</i>-1,2,4-triazole-5-thione
C26H34F2N6S
Acta Crystallographica Section E (2013) 69, 5 o685-o686
a=17.0824(11)Å b=7.8212(6)Å c=19.6691(14)Å
α=90.00° β=92.249(6)° γ=90.00°
5-(Adamantan-1-yl)-3-anilinomethyl-2,3-dihydro-1,3,4-oxadiazole-2-thione
C19H23N3OS
Acta Crystallographica Section E (2013) 69, 5 o729
a=14.1326(13)Å b=7.1179(5)Å c=18.3685(16)Å
α=90.00° β=105.546(10)° γ=90.00°
5-(Adamantan-1-yl)-3-[(4-fluoroanilino)methyl]-2,3-dihydro-1,3,4-oxadiazole-2-thione
C19H22FN3OS
Acta Crystallographica Section E (2013) 69, 5 o730
a=7.1683(8)Å b=10.6621(11)Å c=23.592(3)Å
α=90.00° β=90.00° γ=90.00°
5-(Adamantan-1-yl)-<i>N</i>-methyl-1,3,4-thiadiazol-2-amine
C13H19N3S
Acta Crystallographica Section E (2013) 69, 5 o683
a=10.4394(12)Å b=13.0910(13)Å c=10.8871(15)Å
α=90.00° β=118.008(16)° γ=90.00°
3-(Adamantan-1-yl)-4-methyl-1-({4-[3-(trifluoromethyl)phenyl]piperazin-1-yl}methyl)-4,5-dihydro-1<i>H</i>-1,2,4-triazole-5-thione
C25H32F3N5S
Acta Crystallographica Section E (2013) 69, 5 o695-o696
a=28.8100(15)Å b=6.6052(4)Å c=25.7717(14)Å
α=90.00° β=90.00° γ=90.00°